773 related articles for article (PubMed ID: 30029370)
1. Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
Zhou L; Liu Y; Wang F; Jia Z; Zhou J; Jiang T; Petti L; Chen Y; Xiong Q; Wang X
Talanta; 2018 Oct; 188():238-244. PubMed ID: 30029370
[TBL] [Abstract][Full Text] [Related]
2. Vertical flow assays based on core-shell SERS nanotags for multiplex prostate cancer biomarker detection.
Chen R; Liu B; Ni H; Chang N; Luan C; Ge Q; Dong J; Zhao X
Analyst; 2019 Jul; 144(13):4051-4059. PubMed ID: 31157328
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of expression of PSA, hK2, PSMA in the peripheral blood of patients with prostate cancer].
Cui WG; Zhao H; Song YZ; Zhang J; Zhang LG; Shi JD; Qiang WM
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):479-81. PubMed ID: 15555338
[TBL] [Abstract][Full Text] [Related]
4. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
Becker C; Piironen T; Pettersson K; Björk T; Wojno KJ; Oesterling JE; Lilja H
J Urol; 2000 Jan; 163(1):311-6. PubMed ID: 10604382
[TBL] [Abstract][Full Text] [Related]
5. Label-free determination of prostate specific membrane antigen in human whole blood at nanomolar levels by magnetically assisted surface enhanced Raman spectroscopy.
Chaloupková Z; Balzerová A; Bařinková J; Medříková Z; Šácha P; Beneš P; Ranc V; Konvalinka J; Zbořil R
Anal Chim Acta; 2018 Jan; 997():44-51. PubMed ID: 29149993
[TBL] [Abstract][Full Text] [Related]
6. SERS-Based Pump-Free Microfluidic Chip for Highly Sensitive Immunoassay of Prostate-Specific Antigen Biomarkers.
Gao R; Lv Z; Mao Y; Yu L; Bi X; Xu S; Cui J; Wu Y
ACS Sens; 2019 Apr; 4(4):938-943. PubMed ID: 30864786
[TBL] [Abstract][Full Text] [Related]
7. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
[TBL] [Abstract][Full Text] [Related]
8. Immunoassay for tumor markers in human serum based on Si nanoparticles and SiC@Ag SERS-active substrate.
Zhou L; Zhou J; Feng Z; Wang F; Xie S; Bu S
Analyst; 2016 Apr; 141(8):2534-41. PubMed ID: 27003871
[TBL] [Abstract][Full Text] [Related]
9. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.
Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG
Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595
[TBL] [Abstract][Full Text] [Related]
10. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
11. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA.
Magklara A; Scorilas A; Catalona WJ; Diamandis EP
Clin Chem; 1999 Nov; 45(11):1960-6. PubMed ID: 10545066
[TBL] [Abstract][Full Text] [Related]
12. Highly sensitive immunoassay based on SERS using nano-Au immune probes and a nano-Ag immune substrate.
Shu L; Zhou J; Yuan X; Petti L; Chen J; Jia Z; Mormile P
Talanta; 2014 Jun; 123():161-8. PubMed ID: 24725879
[TBL] [Abstract][Full Text] [Related]
13. Human Kallikrein-2, Prostate Specific Antigen and Free- Prostate Specific Antigen in Combination to Discriminate Prostate Cancer from Benign Diseases in Syrian Patients.
Bachour DM; Chahin E; Al-Fahoum S
Asian Pac J Cancer Prev; 2015; 16(16):7085-8. PubMed ID: 26514494
[TBL] [Abstract][Full Text] [Related]
14. Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL.
Chen N; Rong M; Shao X; Zhang H; Liu S; Dong B; Xue W; Wang T; Li T; Pan J
Int J Nanomedicine; 2017; 12():5399-5407. PubMed ID: 28794631
[TBL] [Abstract][Full Text] [Related]
15. Wash-free magnetic immunoassay of the PSA cancer marker using SERS and droplet microfluidics.
Gao R; Cheng Z; deMello AJ; Choo J
Lab Chip; 2016 Mar; 16(6):1022-9. PubMed ID: 26879372
[TBL] [Abstract][Full Text] [Related]
16. SERS spectroscopy using Au-Ag nanoshuttles and hydrophobic paper-based Au nanoflower substrate for simultaneous detection of dual cervical cancer-associated serum biomarkers.
Lu D; Ran M; Liu Y; Xia J; Bi L; Cao X
Anal Bioanal Chem; 2020 Oct; 412(26):7099-7112. PubMed ID: 32737551
[TBL] [Abstract][Full Text] [Related]
17. Development of sensitive immunoassays for free and total human glandular kallikrein 2.
Väisänen V; Eriksson S; Ivaska KK; Lilja H; Nurmi M; Pettersson K
Clin Chem; 2004 Sep; 50(9):1607-17. PubMed ID: 15247158
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer.
Cheng Z; Choi N; Wang R; Lee S; Moon KC; Yoon SY; Chen L; Choo J
ACS Nano; 2017 May; 11(5):4926-4933. PubMed ID: 28441008
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous and highly sensitive detection of multiple breast cancer biomarkers in real samples using a SERS microfluidic chip.
Zheng Z; Wu L; Li L; Zong S; Wang Z; Cui Y
Talanta; 2018 Oct; 188():507-515. PubMed ID: 30029406
[TBL] [Abstract][Full Text] [Related]
20. Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA.
Scorilas A; Plebani M; Mazza S; Basso D; Soosaipillai AR; Katsaros N; Pagano F; Diamandis EP
Prostate; 2003 Feb; 54(3):220-9. PubMed ID: 12518327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
